Last updated: 11/06/2018 23:40:05
A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy
Trial description: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
B R Boothman, D G Grosset Ease of overnight switching from immediate release ropinirole to once-daily prolonged release ropinirole in early Parkinson’s Disease. Eur J Neurol. September 2006/Suppl 2:13/s2-P1174.
Debra Tompson, Fabrizio Stocchi Relationship between Unified Parkinson’s Disease Rating Scale total motor score and systemic exposure of ropinirole 24 hour prolonged release in patients with early stage Parkinson’s disease Parkinsonism and Related Disorders 2007. Suppl 2. 13-S109/2.242
F Stocchi, B Hersh, L Giorgi Safety and tolerability of Ropinirole 24-hour Prolonged Release in Patients with early and advanced Parkinson’s disease (PD). Eur J Neurol 2007 14 (Issue S1) 1-355
F Stocchi, L Giorgi Efficacy of ropinirole 24-hour prolonged release compared with immediate release formulation in early Parkinson’s disease (PD). The EASE PD Monotherapy Study. Eur J Neurol. September 2006/Suppl 2:13/s2-P2141
Medical condition
Parkinson Disease
Product
ropinirole
Collaborators
Not applicable
Study date(s)
July 2003 to October 2004
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2004-19-10
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website